title: Angiotensin Converting Enzyme Gene Insertion/Deletion Polymorphism and Vesicoureteral Reflux in Children: A Meta-Analysis of 14 Case-Control Studies.
abstract: Vesicoureteral reflux (VUR) is a common and serious urinary disease in children. It usually causes renal scar, urinary tract infection, and chronic renal failure. Previous studies showed the angiotensin converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism might be associated with VUR; however, the conclusions were inconsistent. Therefore we used the meta-analytic approach to clarify the effect of ACE I/D polymorphism on VUR risk.We systematically searched the PubMed, CNKI, and EMBASE databases to identify all the potentially related studies published up to February 4, 2015. Two reviewers independently selected studies and extracted data. The strength of the association was assessed using odd ratio (OR) with its 95% confidence interval (CI) based on fixed or random effects model. The STATA 12.0 software was used for data analysis.A total of 14 case-control studies involving 1197 VUR patients and 1320 healthy controls met the eligibility criteria. Results of meta-analysis showed significant association between ACE I/D polymorphism and VUR risk (D vs. I: OR = 1.28, 95% CI = 1.06-1.54, P = 0.01; DD vs. II: OR = 1.44, 95% CI = 1.12-1.85, P = 0.01; DD vs. DI + II: OR = 1.49, 95% CI = 1.23-1.79, P < 0.01; DD + DI vs. II: OR = 1.20, 95% CI = 0.84-1.72, P = 0.31). Subgroup analyses revealed varied results. In Turkish people, results of all the genetic models other than DI vs. II showed statistical significance; in Caucasians, DD vs. DI + II showed statistical significance; and in Asians, DI versus II showed statistical significance.Our meta-analysis indicated that the ACE I/D polymorphism might be associated with increased risk of VUR in children. However, due to the limitations, we suggest conducting additional studies with larger sample size and adjustment for various risk factors, in the future for further clarification.
authors.affiliation: From the Evidence-Based Medicine Center, Xiangyang Hospital, Hubei University of Medicine, Xiangyang, China (J-WA, YL, QL, LZ, BP); Department of Urology, Center for Evidence-Based Medicine and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China (X-TZ).
authors.forename: Jin-Wei
authors.initials: JW
authors.lastname: Ai
authors.forename: Yu
authors.initials: Y
authors.lastname: Liu
authors.forename: Xian-Tao
authors.initials: XT
authors.lastname: Zeng
authors.forename: Qing
authors.initials: Q
authors.lastname: Lei
authors.forename: Li
authors.initials: L
authors.lastname: Zou
authors.forename: Bin
authors.initials: B
authors.lastname: Pei
mesh_terms: D016022:Case-Control Studies; D002648:Child; D017353:Gene Deletion; D020022:Genetic Predisposition to Disease; D006801:Humans; D016254:Mutagenesis, Insertional; D007703:Peptidyl-Dipeptidase A / Q000235:genetics*; D014718:Vesico-Ureteral Reflux / Q000235:genetics*
chemical_list: D007703:Peptidyl-Dipeptidase A